Full-Time
Fintech platform for advisor crypto-equity SMAs
$125k - $160k/yr
New York, NY, USA
Hybrid
Brooklyn Investment Group builds a platform for financial advisors to manage client wealth through Separately Managed Accounts (SMAs) that combine crypto and traditional equity investments. The platform enables advisors to customize portfolios for each client, charge fees for platform access and portfolio management, and automate tax loss harvesting to boost after-tax returns. A Chief Investment Officer-led team delivers professional risk management and trading using proprietary signals, with experience from major institutions and a focus on disciplined risk controls. The company differentiates itself by integrating crypto and equity in SMAs, offering daily automated tax loss harvesting across both coins and stocks, and by leveraging a seasoned, ML-aware leadership and quantitative engineers. Brooklyn’s goal is to bridge traditional financial advisory services with digital wealth management, giving advisors advanced tools to optimize returns and manage risk for their clients.
Company Size
11-50
Company Stage
Seed
Total Funding
$14.9M
Headquarters
New York City, New York
Founded
2016
Help us improve and share your feedback! Did you find this helpful?
Stock Options
Brooklyn Investment Group acquired a new stake in iShares MSCI China ETF in the 1st quarter worth approximately $60,000.
Brooklyn Investment Group acquired a new stake in Cracker Barrel Old Country Store in the 1st quarter valued at about $30,000.
Brooklyn Investment Group acquired a new stake in Ramaco Resources in the first quarter valued at $25,000.
Nuveen is acquiring Brooklyn Investment Group and its parent technology company to expand in direct indexing, a growing investment management area. Direct indexing allows for tax advantages and portfolio customization. Nuveen aims to integrate alternatives and lifetime income into tax-advantaged offerings, enhance client experience, and use Brooklyn's technology. Nuveen, a TIAA subsidiary, managed $1.3 trillion in assets as of March 31. Terms of the deal were not disclosed.
Brooklyn Investment Group acquired a new stake in Apogee Therapeutics in the 1st quarter valued at about $42,000.